Semaglutide Improves Walking Capacity in Peripheral Artery Disease: STRIDE Trial Written By Dr Riya Dave3 April 2026 10:00 AM ISTResearchers have found in the STRIDE trial that semaglutide significantly improved walking capacity in patients with peripheral artery disease (PAD)....
Hetero Launches Generic Semaglutide Brands Truglyx, Rolmodl, Moto G Across 75+ Countries Written By sheeba farhat28 March 2026 8:22 PM ISTNew Delhi: Hetero has announced the export launch of its generic semaglutide portfolio, marking a significant step toward expanding access to GLP-1...
Delhi HC Bars Dr Reddy's from Selling Olymviq Over Similarity with Novo Nordisk's Ozempic Written By Susmita Roy27 March 2026 10:16 PM ISTNew Delhi: The Delhi High Court on Wednesday directed Dr. Reddy's Laboratories to temporarily stop selling its diabetes drug marketed under the brand...
GLP-1 Receptor Agonists May Reduce Risk of Glaucoma: Study Written By Dr Riya Dave27 March 2026 9:00 PM ISTResearchers have found in a narrative review that GLP-1 receptor agonists may significantly lower the risk of ocular hypertension and glaucoma,...
Semaglutide Misuse Under Watch: Telangana DCA Issues Advisory After Generic Launch Surge Written By Susmita Roy26 March 2026 11:30 PM ISTNew Delhi: In response to the growing demand and widespread use of Semaglutide formulations following the patent expiry of innovator products in March...
Combination GLP-1 therapy shows fat mass loss while preserving lean mass in adults with obesity: Study Written By Dr. Kamal Kant Kohli25 March 2026 9:00 PM ISTA recent research study found that a combination of the GLP-1 receptor agonist semaglutide and bimagrumab, an antibody that blocks activin signaling...
Dr Reddy's Labs Gets SEC Nod to Manufacture, Market Oral Semaglutide Tablets Written By Susmita Roy25 March 2026 8:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) has recommended granting permission to Dr....
GLP-1 Drugs Improve Metabolic Outcomes in Cushing's Syndrome Without Hormonal Harm: Study Written By Dr Riya Dave24 March 2026 8:45 AM ISTResearchers have discovered in a new study that among patients with Cushing's syndrome, treatment with GLP-1 drugs led to significant weight loss and...
Weight Loss Drugs in Early Pregnancy Linked to Premature Birth Risk in Diabetics: Study Written By Dr. Kamal Kant Kohli23 March 2026 8:30 PM ISTWeight loss drugs have been linked to an increased risk of premature births among women who took them inadvertently just before or during early...
USV Launches USEMA - DCGI-Approved Injectable Semaglutide for Type 2 Diabetes Written By Dr. Nandita Mohan21 March 2026 11:02 AM ISTUSV Private Limited, a leading name in diabetes care, has announced the launch of USEMA, its semaglutide injection, for the management of Type 2...
USFDA Approves Higher-Dose Wegovy to Boost Weight Loss Outcomes Written By sheeba farhat21 March 2026 11:00 AM ISTWashington: Federal regulators on Thursday approved a new higher-dose version of the blockbuster obesity drug Wegovy that may help users lose more...
Semaglutide Patent Expiry Sparks Generic Rush in India, Prices Set to Drop Sharply Written By sheeba farhat20 March 2026 11:13 PM ISTHyderabad: India's market for diabetes and weight-loss drugs is set for a shake-up as Danish drugmaker Novo Nordisk's patent on semaglutide expires...
